BCRX 8-K 2026-01-12

BIOCRYST PHARMACEUTICALS INC (BCRX) 8-K dated 2026-01-12 — accession 0001171843-26-000213. This URL is the filing, not the BCRX hub.

BIOCRYST PHARMACEUTICALS INC (BCRX) is a drug manufacturers - specialty & generic company listed on US.

BIOCRYST PHARMACEUTICALS INC filed a 8-K on 2026-01-12. Accession 0001171843-26-000213.

Cached items: 2.02, 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. BCRX currently screens at market cap $1.83B.

Not investment advice. The BCRX SEC hub lists recent forms. The stock page is the research view.